---
title: "Broncus shareholders back all AGM resolutions, update articles of association"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286439966.md"
description: "Broncus Holding Corp. announced that all resolutions at its May 14, 2026 AGM were approved by shareholders. This includes the approval of the 2025 audited financial statements, reappointment of Ernst & Young as auditor, and mandates for share issuance and buybacks. Shareholders also re-elected two non-executive directors, with varying support levels. A special resolution to amend the articles of association was also passed, enhancing the board's flexibility in capital management and governance. Broncus is a Cayman Islands-based medical company listed in Hong Kong, focusing on healthcare technologies."
datetime: "2026-05-14T15:08:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286439966.md)
  - [en](https://longbridge.com/en/news/286439966.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286439966.md)
---

# Broncus shareholders back all AGM resolutions, update articles of association

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Broncus Holding Corp. ( (HK:2216) ) has shared an update.

Broncus Holding Corporation reported that all resolutions proposed at its 14 May 2026 annual general meeting were duly passed by shareholders via poll voting. Investors approved the 2025 audited financial statements, reappointed Ernst & Young as auditor, renewed authority for the board to set director pay, and granted mandates for share issuance and buybacks within defined limits.

Shareholders also endorsed the re-election of two non-executive directors, though support for Yanhong Kuang was notably lower than for Ao Zhang, highlighting some investor divergence on board composition. A special resolution to amend the company’s articles of association was comfortably approved, giving the board updated constitutional flexibility that could affect future capital management and governance arrangements.

**More about Broncus Holding Corp.**

Broncus Holding Corporation is a Cayman Islands–incorporated medical company listed in Hong Kong, focusing on healthcare technologies and related services. The group operates through subsidiaries and is overseen by a board comprising executive, non-executive and independent directors, reflecting a typical governance structure for a listed medical holdings firm.

**Average Trading Volume:** 759,677

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$549.9M

### Related Stocks

- [562600.CN](https://longbridge.com/en/quote/562600.CN.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [159898.CN](https://longbridge.com/en/quote/159898.CN.md)
- [02216.HK](https://longbridge.com/en/quote/02216.HK.md)

## Related News & Research

- [Basecare Wins NMPA Class III Approval for Gems Embryo Culture Medium](https://longbridge.com/en/news/286258287.md)
- [DOJ Launches Criminal Probe Into Blue State Hospital](https://longbridge.com/en/news/286157785.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [Hong Kong’s MPF authority flags fraudulent certificates in early pension payouts](https://longbridge.com/en/news/286657515.md)
- [UAE among first globally to approve new obesity, hypertension treatments](https://longbridge.com/en/news/286707352.md)